Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Gilbert

Showing results (41-50 of 215) with videos related to

Pageof 22
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2017
Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus ChallengeClaire M Tully, Senthil Chinnakannan, Caitlin E Mullarkey, et al.
Plos One|February 21, 2008
Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA)Matthew G Cottingham, Rikke F Andersen, Alexandra J Spencer, et al.
Vaccine|October 13, 2010
Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1Alexander D Douglas, Simone C de Cassan, Matthew D J Dicks, et al.
Cell Host & Microbe|September 15, 2017
Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against MalariaSimon J Draper, Anna L Goodman, Sumi Biswas, et al.
Scientific Reports|November 19, 2015
Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in miceMatthew D J Dicks, Alexandra J Spencer, Lynda Coughlan, et al.
Cell Host & Microbe|January 22, 2009
Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malariaSimon J Draper, Anna L Goodman, Sumi Biswas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2012
Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protectionSumi Biswas, Alexandra J Spencer, Emily K Forbes, et al.
The Journal of Infectious Diseases|November 20, 2019
Modified Vaccinia Ankara-Vectored Vaccine Expressing Nucleoprotein and Matrix Protein 1 (M1) Activates Mucosal M1-Specific T-Cell Immunity and Tissue-Resident Memory T Cells in Human Nasopharynx-Associated Lymphoid TissueSuttida Puksuriwong, Muhammad S Ahmed, Ravi Sharma, et al.
Immunology and Cell Biology|March 17, 2010
Immunogenicity and protective efficacy of mycobacterial DNA vaccines incorporating plasmid-encoded cytokines against Mycobacterium bovisSarah L Young, Lynn J Slobbe, Matthew Peacey, et al.
Vaccine|January 29, 2015
The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target speciesMatthew D J Dicks, Efrain Guzman, Alexandra J Spencer, et al.
Pageof 22

Showing results (41-50 of 215) with videos related to

Sort By:
Pageof 22
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2017
Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus ChallengeClaire M Tully, Senthil Chinnakannan, Caitlin E Mullarkey, et al.
Plos One|February 21, 2008
Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA)Matthew G Cottingham, Rikke F Andersen, Alexandra J Spencer, et al.
Vaccine|October 13, 2010
Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1Alexander D Douglas, Simone C de Cassan, Matthew D J Dicks, et al.
Cell Host & Microbe|September 15, 2017
Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against MalariaSimon J Draper, Anna L Goodman, Sumi Biswas, et al.
Scientific Reports|November 19, 2015
Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in miceMatthew D J Dicks, Alexandra J Spencer, Lynda Coughlan, et al.
Cell Host & Microbe|January 22, 2009
Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malariaSimon J Draper, Anna L Goodman, Sumi Biswas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2012
Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protectionSumi Biswas, Alexandra J Spencer, Emily K Forbes, et al.
The Journal of Infectious Diseases|November 20, 2019
Modified Vaccinia Ankara-Vectored Vaccine Expressing Nucleoprotein and Matrix Protein 1 (M1) Activates Mucosal M1-Specific T-Cell Immunity and Tissue-Resident Memory T Cells in Human Nasopharynx-Associated Lymphoid TissueSuttida Puksuriwong, Muhammad S Ahmed, Ravi Sharma, et al.
Immunology and Cell Biology|March 17, 2010
Immunogenicity and protective efficacy of mycobacterial DNA vaccines incorporating plasmid-encoded cytokines against Mycobacterium bovisSarah L Young, Lynn J Slobbe, Matthew Peacey, et al.
Vaccine|January 29, 2015
The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target speciesMatthew D J Dicks, Efrain Guzman, Alexandra J Spencer, et al.
Pageof 22